BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 29227930)

  • 21. Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies.
    Singh H; Singh JV; Gupta MK; Saxena AK; Sharma S; Nepali K; Bedi PMS
    Bioorg Med Chem Lett; 2017 Sep; 27(17):3974-3979. PubMed ID: 28797799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, antimycobacterial and antibacterial activity of fluoroquinolone derivatives containing an 3-alkoxyimino-4-(cyclopropylanimo)methylpyrrolidine moiety.
    Zhang T; Shen W; Liu M; Zhang R; Wang M; Li L; Wang B; Guo H; Lu Y
    Eur J Med Chem; 2015 Nov; 104():73-85. PubMed ID: 26435513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
    Gatadi S; Gour J; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
    Eur J Med Chem; 2019 Aug; 175():287-308. PubMed ID: 31096152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benzofuran-isatin-imine hybrids tethered via different length alkyl linkers: Design, synthesis and in vitro evaluation of anti-tubercular and anti-bacterial activities as well as cytotoxicity.
    Gao F; Wang T; Gao M; Zhang X; Liu Z; Zhao S; Lv Z; Xiao J
    Eur J Med Chem; 2019 Mar; 165():323-331. PubMed ID: 30690301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naphthoquinones isolated from Diospyros anisandra exhibit potent activity against pan-resistant first-line drugs Mycobacterium tuberculosis strains.
    Uc-Cachón AH; Borges-Argáez R; Said-Fernández S; Vargas-Villarreal J; González-Salazar F; Méndez-González M; Cáceres-Farfán M; Molina-Salinas GM
    Pulm Pharmacol Ther; 2014 Feb; 27(1):114-20. PubMed ID: 23968826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of 1H-1,2,3-triazole linked β-lactam-isatin bi-functional hybrids and preliminary analysis of in vitro activity against the protozoal parasite Trichomonas vaginalis.
    Raj R; Singh P; Haberkern NT; Faucher RM; Patel N; Land KM; Kumar V
    Eur J Med Chem; 2013 May; 63():897-906. PubMed ID: 23631874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of novel 1H-1,2,3-triazole tethered C-5 substituted uracil-isatin conjugates and their cytotoxic evaluation.
    Kumar K; Sagar S; Esau L; Kaur M; Kumar V
    Eur J Med Chem; 2012 Dec; 58():153-9. PubMed ID: 23124212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel thiomorpholine tethered isatin hydrazones as potential inhibitors of resistant Mycobacterium tuberculosis.
    Karunanidhi S; Chandrasekaran B; Karpoormath R; Patel HM; Kayamba F; Merugu SR; Kumar V; Dhawan S; Kushwaha B; Mahlalela MC
    Bioorg Chem; 2021 Oct; 115():105133. PubMed ID: 34329993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and synthesis of 1H-1,2,3-triazoles derived from econazole as antitubercular agents.
    Kim S; Cho SN; Oh T; Kim P
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6844-7. PubMed ID: 23058885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of novel isatin-nicotinohydrazide hybrids with potent activity against susceptible/resistant
    Elsayed ZM; Eldehna WM; Abdel-Aziz MM; El Hassab MA; Elkaeed EB; Al-Warhi T; Abdel-Aziz HA; Abou-Seri SM; Mohammed ER
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):384-393. PubMed ID: 33406941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular hybridization approach for phenothiazine incorporated 1,2,3-triazole hybrids as promising antimicrobial agents: Design, synthesis, molecular docking and in silico ADME studies.
    Reddyrajula R; Dalimba U; Madan Kumar S
    Eur J Med Chem; 2019 Apr; 168():263-282. PubMed ID: 30822714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and in vitro antimycobacterial activity of 8-OCH(3) ciprofloxacin methylene and ethylene isatin derivatives.
    Feng LS; Liu ML; Zhang S; Chai Y; Wang B; Zhang YB; Lv K; Guan Y; Guo HY; Xiao CL
    Eur J Med Chem; 2011 Jan; 46(1):341-8. PubMed ID: 21146257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and evaluation of 1,2,3-triazole-adamantylacetamide hybrids as potent inhibitors of Mycobacterium tuberculosis.
    Addla D; Jallapally A; Gurram D; Yogeeswari P; Sriram D; Kantevari S
    Bioorg Med Chem Lett; 2014 Apr; 24(8):1974-9. PubMed ID: 24679703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel benzimidazole-acrylonitrile hybrids and their derivatives: Design, synthesis and antimycobacterial activity.
    Sirim MM; Krishna VS; Sriram D; Unsal Tan O
    Eur J Med Chem; 2020 Feb; 188():112010. PubMed ID: 31893548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorinated 1,2,4-Triazolo[1,5-a]pyrimidine-6-carboxylic acid derivatives as antimycobacterial agents.
    Abdel-Rahman HM; El-Koussi NA; Hassan HY
    Arch Pharm (Weinheim); 2009 Feb; 342(2):94-9. PubMed ID: 19173243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and evaluation of α-ketotriazoles and α,β-diketotriazoles as inhibitors of Mycobacterium tuberculosis.
    Menendez C; Rodriguez F; Ribeiro AL; Zara F; Frongia C; Lobjois V; Saffon N; Pasca MR; Lherbet C; Baltas M
    Eur J Med Chem; 2013 Nov; 69():167-73. PubMed ID: 24016834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, molecular docking, and biological evaluation of novel 1,2,4-triazole-isatin derivatives as potential Mycobacterium tuberculosis shikimate kinase inhibitors.
    Dadlani VG; Chhabhaiya H; Somani RR; Tripathi PK
    Chem Biol Drug Des; 2022 Aug; 100(2):230-244. PubMed ID: 35434882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-tubercular agents. Part 8: synthesis, antibacterial and antitubercular activity of 5-nitrofuran based 1,2,3-triazoles.
    Kamal A; Hussaini SM; Faazil S; Poornachandra Y; Narender Reddy G; Kumar CG; Rajput VS; Rani C; Sharma R; Khan IA; Jagadeesh Babu N
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6842-6. PubMed ID: 24206766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Triazole derivatives and their anti-tubercular activity.
    Zhang S; Xu Z; Gao C; Ren QC; Chang L; Lv ZS; Feng LS
    Eur J Med Chem; 2017 Sep; 138():501-513. PubMed ID: 28692915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and molecular modeling studies on novel moxifloxacin derivatives as potential antibacterial and antituberculosis agents.
    Türe A; Kulabaş N; Dingiş Sİ; Birgül K; Bozdeveci A; Alpay Karaoğlu Ş; Krishna VS; Sriram D; Küçükgüzel İ
    Bioorg Chem; 2019 Jul; 88():102965. PubMed ID: 31085371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.